Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Limited efficacy of a four-day course of high-dose cytosine arabinoside in the treatment of poor-risk patients with acute nonlymphocytic leukemia.

Preisler HD, Raza A, Larson R, Browman G, Goldberg J, Grunwald H, Vogler R, Bennett J, Gottlieb A, D'Arrigo P. Limited efficacy of a four-day course of high-dose cytosine arabinoside in the treatment of poor-risk patients with acute nonlymphocytic leukemia. Cancer Chemother Pharmacol. 1986; 18(3):257-60.

View in: PubMed

collapse authors with profiles